Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Image

First CD123-targeted ADC secures FDA approval for rare blood cancer

Journal content Created on 11 Jun 2026 Nature Reviews Drug Discovery

Published in

Nature Reviews Drug Discovery, Nature Publishing Group

Content

There is no additional content. Please click on the source link to view more information.

Asher Mullard

Advertisement

Stats

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 41
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement